Mainz Biomed (MYNZ) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Mainz Biomed (MYNZ) over the last 6 years, with Q2 2025 value amounting to -$6.2 million.
- Mainz Biomed's Enterprise Value rose 1181.25% to -$6.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$6.2 million, marking a year-over-year increase of 1181.25%. This contributed to the annual value of -$6.2 million for FY2024, which is 1181.25% up from last year.
- Mainz Biomed's Enterprise Value amounted to -$6.2 million in Q2 2025, which was up 1181.25% from -$6.2 million recorded in Q4 2024.
- In the past 5 years, Mainz Biomed's Enterprise Value ranged from a high of -$6.2 million in Q4 2024 and a low of -$26.0 million during Q2 2022
- Its 5-year average for Enterprise Value is -$11.8 million, with a median of -$8.7 million in 2021.
- As far as peak fluctuations go, Mainz Biomed's Enterprise Value plummeted by 702057.14% in 2021, and later surged by 5875.03% in 2023.
- Mainz Biomed's Enterprise Value (Quarter) stood at -$8.7 million in 2021, then crashed by 96.41% to -$17.1 million in 2022, then surged by 58.75% to -$7.1 million in 2023, then rose by 11.81% to -$6.2 million in 2024, then changed by 0.0% to -$6.2 million in 2025.
- Its Enterprise Value was -$6.2 million in Q2 2025, compared to -$6.2 million in Q4 2024 and -$7.1 million in Q2 2024.